One study by Viale et al. [46] examined Ki-67 in 1924 patients enrolled in two randomized International Breast Cancer Study Group trials of adjuvant chemoendocrine therapy vs. endocrine therapy alone for node-negative breast cancer. Here, MKI67 is linked to breast carcinoma.